Prognosis and tumor microenvironment in pseudohypoxic pheochromocytoma/paraganglioma
Virchows Archiv · 2025
DOI: 10.1007/s00428-024-04009-x ↗Kurz gefasst
Fachartikel in der Zeitschrift Virchows Archiv, 2025. Verfasst von Akihiro Ohmoto und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-ku, Tokyo, 1358550, Japan. …. Hauptthemen laut MEDLINE: Tumor Microenvironment, Pheochromocytoma, Adrenal Gland Neoplasms, Paraganglioma. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: Japanese Foundation for Cancer Research Fund.
Abstract (Originalsprache)
Pheochromocytoma and paraganglioma (PPGL) are rare tumors that occur in the adrenal medulla and extra-adrenal tissues, respectively. The prognosis and tumor microenvironment (TME) of pseudohypoxic PPGL as a major entity have not been fully described. Based on the clinical database of 65 patients with PPGL, we assessed the morphological features as well as the immunohistochemistry of pseudohypoxia-related proteins (SDHB and CAIX) and TME-related immune cell markers. Furthermore, we compared the relapse-free survival (RFS) rates in localized patients between the pathological subgroups. Among 50 available specimens, 84% and 30% of the cases exhibited at least one morphological adverse feature including vascular/capsular invasion and a Ki-67 index > 3%, respectively. The SDHB and CAIX positivity rates were 81% and 51%. Concerning the immune cell markers, the CD163-positive cell numbers were higher in hypoxia-associated PPGL composed of SDHB-negative or CAIX-positive cases than in non-hypoxia PPGL (median 66 vs. 23/mm2). Concerning prognosis, RFS rates were significantly lower in cases with Ki-67 indices > 3% and SDHB-negativity than in those with Ki-67 indices ≤ 3% and SDHB-positivity (3-year rate: 64% vs. 100%, P < 0.001; 57% vs. 100%, P = 0.03). In contrast, RFS was comparable between CAIX-positive and CAIX-negative PPGL cases. Our analyses suggested that SDHB-deficient PPGL exhibited a higher incidence of relapse. Furthermore, M2 macrophage infiltration in TME might be crucial in pseudohypoxic PPGL pathogenesis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Oncology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-ku, Tokyo, 1358550, Japan. aohmoto15@gmail.com.
- Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, 417 East 68th Street, New York, NY, 10065, USA. aohmoto15@gmail.com.
- Department of Pathology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-ku, Tokyo, 1358550, Japan.
- Division of Pathology, Cancer Institute of Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-ku, Tokyo, 1358550, Japan.
- Department of Medical Oncology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-ku, Tokyo, 1358550, Japan.
- Department of Clinical Chemotherapy, Cancer Chemotherapy Center, Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-ku, Tokyo, 1358550, Japan.
Förderung
- Japanese Foundation for Cancer Research Fund
Zitieren
APA
Ohmoto, A., Shigematsu, Y., Saito, R., Dobashi, A., Fujiwara, Y., Togashi, Y., Yonese, J., Inamura, K., & Takahashi, S. (2025). Prognosis and tumor microenvironment in pseudohypoxic pheochromocytoma/paraganglioma. Virchows Archiv. https://doi.org/10.1007/s00428-024-04009-x
Vancouver
Ohmoto A, Shigematsu Y, Saito R, Dobashi A, Fujiwara Y, Togashi Y, et al. Prognosis and tumor microenvironment in pseudohypoxic pheochromocytoma/paraganglioma. Virchows Archiv. 2025. doi:10.1007/s00428-024-04009-x
BibTeX
@article{Ohmoto2025,
author = {Ohmoto, Akihiro and Shigematsu, Yasuyuki and Saito, Rumiko and Dobashi, Akito and Fujiwara, Yu and Togashi, Yuki and Yonese, Junji and Inamura, Kentaro and Takahashi, Shunji},
title = {Prognosis and tumor microenvironment in pseudohypoxic pheochromocytoma/paraganglioma},
journal = {Virchows Archiv},
year = {2025},
doi = {10.1007/s00428-024-04009-x}
}
EUVIMED